Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessHighly AccessResearch

beta1-integrin mediates myelin-associated glycoprotein signaling in neuronal growth cones

Eyleen LK Goh1,2* email, Ju Kim Young1,2* email, Kenichiro Kuwako3 email, Marc Tessier-Lavigne4 email, Zhigang He3 email, John W Griffin2,5 email and Guo-li Ming1,2,5 email

Institute for Cell Engineering, The Johns Hopkins University School of Medicine, MD 21205, USA

Department of Neurology, The Johns Hopkins University School of Medicine, MD 21205, USA

Division of Neuroscience, Children's Hospital, Boston, MA 02115, USA

Division of Research, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA

The Solomon H. Snyder Department of Neuroscience, The Johns Hopkins University School of Medicine, MD 21205, USA

author email corresponding author email* Contributed equally

Molecular Brain 2008, 1:10doi:10.1186/1756-6606-1-10

Published: 15 October 2008

Abstract

Several myelin-associated factors that inhibit axon growth of mature neurons, including Nogo66, myelin-associated glycoprotein (MAG) and oligodendrocyte myelin glycoprotein (OMgp), can associate with a common GPI-linked protein Nogo-66 receptor (NgR). Accumulating evidence suggests that myelin inhibitors also signal through unknown NgR-independent mechanisms. Here we show that MAG, a RGD tri-peptide containing protein, forms a complex with β1-integrin to mediate axonal growth cone turning responses of several neuronal types. Mutations that alter the RGD motif in MAG or inhibition of β1-integrin function, but not removal of NgRs, abolish these MAG-dependent events. In contrast, OMgp-induced repulsion is not affected by inhibition of b1-integrin function. We further show that MAG stimulates tyrosine phosphorylation of focal adhesion kinase (FAK), which in turn is required for MAG-induced growth cone turning. These studies identify β1-integrin as a specific mediator for MAG in growth cone turning responses, acting through FAK activation.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.